Luca Molinaro

A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer

Andrea Bertotti, Giorgia Migliardi, Francesco Galimi et al. · Cancer Discovery · 2011 · 938 citations · Full text

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

Richard Sylvester, Óscar Rodríguez, Virginia Hernández et al. · European Urology · 2021 · 415 citations

Urological Research, Urology, Cancer Risk +12

Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma

Chiara Gai, Francesco Camussi, Roberto Broccoletti et al. · BMC Cancer · 2018 · 186 citations · Full text

Thymidylate Synthase But Not Excision Repair Cross-Complementation Group 1 Tumor Expression Predicts Outcome in Patients With Malignant Pleural Mesothelioma Treated With Pemetrexed-Based Chemotherapy

Luisella Righi, Mauro Papotti, Paolo Ceppi et al. · Journal of Clinical Oncology · 2010 · 159 citations · Full text

MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue

Anna Sapino, Paul Roepman, Sabine C. Linn et al. · Journal of Molecular Diagnostics · 2014 · 116 citations · Full text

Histopathology, Mammaprint Molecular Diagnostics, Pathology +4